The Future of Regulatory Processes in Cell and Gene Therapy

EP: 1.The Mission Behind CAR T-cell Clinical Trials

EP: 2.Key Challenges within CAR T-cell Clinical Trials

EP: 3.Approaching Institutional Biosafety Committee Approval for CAR T-cell Therapy

EP: 4.FDA Regulations for CAR T-cell Therapy

Now Viewing

EP: 5.The Future of Regulatory Processes in Cell and Gene Therapy

EP: 6.Site Selection for CAR T-cell Trials

EP: 7.Collaboration with Clinical Trial Sites

EP: 8.Patient Selection and Recruitment for Clinical Trials

EP: 9.Looking Towards the Future of CAR T-cell Trials

EP: 10.Final Thoughts

Regulatory agencies are open to changes within the review process which means the uptake of CAR T-cell therapy will change the landscape itself. This is especially true with large-scale commercialization. Information sharing between global agencies will also be helpful in advancing the science forward.